LORI SLAVICK: Open Payments
NPI 1104037464 · CHAMBERSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 29 payments from 9 companies in 2025. Trend: 2023 $902 · 2024 $816 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127 |
| Supernus Pharmaceuticals, Inc. | 5 | $113 |
| ABBVIE INC. | 4 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Alkermes, Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: TRINTELLIX, Qelbree, VRAYLAR, COBENFY, REXULTI, Auvelity, LYBALVI, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
